Literature DB >> 6323237

In vivo stimulation of low-density lipoprotein degradation by insulin.

T Mazzone, D Foster, A Chait.   

Abstract

The effect of insulin on low-density lipoprotein (LDL) metabolism in vivo was evaluated using the euglycemic insulin clamp technique. In seven subjects, mononuclear cells isolated after a 4-h insulin infusion degraded more 125I-labeled LDL than cells isolated after a saline infusion in six control subjects. In addition, insulin caused the accelerated disappearance of 125I-labeled LDL from plasma in subjects previously injected with autologous 125I-LDL. Infusion of saline had no such effect. These data suggest that insulin, in vivo, stimulates LDL catabolism and could thereby influence LDL cholesterol levels. Insulin-induced stimulation of LDL catabolism could account for the reduction of LDL-cholesterol levels observed in intensively treated type I diabetic patients.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6323237     DOI: 10.2337/diab.33.4.333

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  19 in total

Review 1.  Pathophysiology of dyslipidaemia in the metabolic syndrome.

Authors:  G D Kolovou; K K Anagnostopoulou; D V Cokkinos
Journal:  Postgrad Med J       Date:  2005-06       Impact factor: 2.401

2.  Reduced hepatic sterol carrier protein-2 expression in the streptozotocin treated diabetic rat.

Authors:  M P McLean; K Nanjo; R B Irby; K J Warden; J T Billheimer
Journal:  Endocrine       Date:  1995-08       Impact factor: 3.633

Review 3.  Statins in nonalcoholic fatty liver disease and steatohepatitis: updated review.

Authors:  William Nseir; Mahmud Mahamid
Journal:  Curr Atheroscler Rep       Date:  2013-03       Impact factor: 5.113

4.  Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss diet.

Authors:  Dick C Chan; Gerald F Watts; Seng Khee Gan; Esther M M Ooi; P Hugh R Barrett
Journal:  Diabetes Care       Date:  2010-02-25       Impact factor: 19.112

5.  Insulin acutely inhibits intestinal lipoprotein secretion in humans in part by suppressing plasma free fatty acids.

Authors:  Mirjana Pavlic; Changting Xiao; Linda Szeto; Bruce W Patterson; Gary F Lewis
Journal:  Diabetes       Date:  2009-12-22       Impact factor: 9.461

6.  Reduction of platelet aggregation induced by euglycaemic insulin clamp.

Authors:  K Hiramatsu; H Nozaki; S Arimori
Journal:  Diabetologia       Date:  1987-05       Impact factor: 10.122

7.  Effect of insulin on low-density-lipoprotein metabolism in human lymphocytes in vitro.

Authors:  S Suresh; V Warty; M Virji; A Sanghvi
Journal:  Biochem J       Date:  1986-01-15       Impact factor: 3.857

8.  Different postprandial acute response in healthy subjects to three strawberry jams varying in carbohydrate and antioxidant content: a randomized, crossover trial.

Authors:  Idoia Ibero-Baraibar; Marta Cuervo; Santiago Navas-Carretero; Itziar Abete; M Angeles Zulet; J Alfredo Martinez
Journal:  Eur J Nutr       Date:  2013-04-04       Impact factor: 5.614

9.  Lipoprotein kinetics in the metabolic syndrome: pathophysiological and therapeutic lessons from stable isotope studies.

Authors:  Dick C Chan; P Hugh R Barrett; Gerald F Watts
Journal:  Clin Biochem Rev       Date:  2004-02

10.  Effects of nasal CPAP treatment on insulin resistance, lipid profile, and plasma leptin in sleep apnea.

Authors:  Cağlar Cuhadaroğlu; Ayfer Utkusavaş; Levent Oztürk; Serpil Salman; Turhan Ece
Journal:  Lung       Date:  2009-01-07       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.